Advertisement

Topics

Latest Biotechnology, Pharmaceutical and Healthcare News from BioNow

08:04 EST 22nd November 2017 | BioPortfolio

Here are the most relevant search results for "BioNow" found in our extensive news archives from over 250 global news sources.

More Information about BioNow on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about BioNow for you to read. Along with our medical data and news we also list BioNow Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioNow Companies for you to search.

Showing News Articles 1–25 of 1,000+ from BioNow

Wednesday 22nd November 2017

Glythera demonstrates improved activity and safety of PermaLink®-based ADCs

Glythera demonstrates improved activity and safety of PermaLink®-based ADCsAppoints Scientific Advisory Board-Significantly improved tolerability of ADCs incorporating highly potent toxins--Efficacy outperforms industry-standard ADC technology –-Development of proprietary ADC pipeline supported by key industry appointments to SAB-Glythera Limited (‘Glythera’), the next genera...

Stellar success showcased in The Times SuperNorth – published today!

The front page signals a clear call to action to the Government to unlock opportunities to deliver growth - voiced by a delegation including Bionow Members in a round table discussion chaired by the Prime Minister.  SuperNorth showcases the achievements of the winners at the 15th Bionow Annual Awards Dinner on Page 2.   Microbiosensor, Magnesium Elektron, Cobra Biologics, Perfectus ...

Call to Action – UK Industrial Strategy

The latest Super North Life science Issue is published with The Times today and delivers a clear message on the need to unlock opportunities to deliver growth. Unless the booming life sciences sector is given better access to help the NHS with innovative products, not only will the health service continue to suffer but some UK medical companies will struggle to stay in the UK as they grow.  T...

European Medicines Agency to relocate to Amsterdam - The wait is over

Accessibility for delegates and experts and staff retention had been seen by the EMA as key to ensuring the EMA’s ability to function. EMA Executive Director, Guido Rasioffers, said that Amsterdam offers excellent connectivity and a building that can be shaped according to the EMA’s needs. Link to EMA announcement. On its own website, the EMA has acknowledged the short time scale and ...

Shining lights of Northern life sciences shortlisted for Bionow Awards

The leading scientists and pioneering entrepreneurs driving the growth of the North of England’s £11bn life science sector have been recognised with the announcement of the shortlist for this year’s Bionow Awards. Organised by Bionow, a not-for-profit membership organisation that supports the life sciences sector across the North, the awards will be announced on 30 November at t...

Monday 20th November 2017

Magnesium Elektron launches new biomedical solutions using magnesium alloys

Magnesium Elektron, a global materials technology company specialising in the design and manufacture of high performance materials, today announced the launch of magnesium for its first biomedical applications. The use of the bioresorbable material, specifically Magnesium Elektron’s revolutionary Synermag® magnesium alloy, in CE approved, cardiovascular applications has been announced. A...

Byotrol Completes Winch Pharma Takeover

Daresbury-based antimicrobial hygiene company Byotrol has acquired the entire share capital of Winch Pharma Consumer Healthcare. The acquired business, which is headquartered in Leeds, is in the midst of a one-year deal to supply the NHS Supply Chain (NHSSC) with non-alcohol hand sanitising and other surface disinfection products under the Athenian brand. Prior to the acquisition, Byotrol was su...

C4X To Raise Up To £7M

Manchester-headquartered drug researcher C4X Discovery has unveiled plans for a £7m share placing. The company has announced a proposed conditional placing to raise up to £7m before expenses via a placing of up to 8.2 million shares, representing approximately 22 per cent of its issued share capital, to current and new institutional investors. The net proceeds of the placing will be u...

Friday 17th November 2017

Poor aggregation will see ADC targets fail or face long delays

ADC Biotechnology (ADC Bio)‘s leading experts warn that best in class ADCs are being overlooked due to critical aggregation control problems. CDMOs are unable to develop products which are capable of working successfully in clinical testing or which are economically viable. The warning comes as more and more full service CDMOs are investing in conjugation and ADC facilities. “There is ...

Thursday 16th November 2017

Magnesium Elektron Announces Long-term Research and Development Collaboration with BIOTRONIK and Production of SynerMag® 410 Bioresorbable Alloy System

The two companies entered into a joint research and development program in 2006 aimed at developing a bioresorbable magnesium coronary scaffold. The ten-year research program has resulted in Elektron’s SynerMag® 410 alloy system being used as the platform material in the BIOTRONIK Magnesium Scaffold, the world’s first clinically proven magnesium-based bioresorbable scaffold.The lat...

Tuesday 14th November 2017

Making more of Patent Box

The Patent Box initiative was established to encourage innovation and investment in the UK, particularly in R&D-rich sectors such as the advanced manufacturing, pharmaceutical and technology industries. While the scheme is obviously most beneficial to businesses that invest in innovation on an on-going basis, it makes sense for companies of all sizes to sign up to the scheme because any tax re...

Major UK investment to boost influenza vaccine production, jobs and exports

Nearly a hundred new high tech jobs are to be created at the Liverpool manufacturing site of Seqirus, one of the world’s largest influenza vaccine companies, as a result of major new investment. The Liverpool site manufactures bulk material for a range of influenza vaccines, including an adjuvanted influenza vaccine designed for people aged 65 years and above. The bulk material is currently ...

Monday 13th November 2017

Companies urged to take part in pioneering health programme

Companies are being invited to apply for funding as part of Durham Smart County, the open innovation programme which has seen Durham County Council join forces with health organisations, universities, community groups, and private companies. INNOVATIVE organisations are being urged to take part in a pioneering initiative to tackle the major health issues associated with social isolation in th...

Sunday 12th November 2017

Graphene quntum dots from Strem Chemicals UK

Dotz Nano is a nano-technology company focusing on the development, manufacture and commercialisation of graphene quantum dots (GQDs). With this agreement in place, Strem Chemicals will become a global distributor of Graphene Quantum Dots. Dotz Nano Ltd. uses low-cost, raw material to make high-quality, cost-effective products. These products can be used in various applications, such as sensing, c...

Thursday 9th November 2017

Free Research Data Management Resource - LABKEY SERVER

Is this you? You are a growing life science research organisation, probably using Microsoft Excel and perhaps other tools to capture, manage, share and analyse different types of data across the business and with external collaborators. You have data here, some data there, but none of it contextualised or centralised. There is no 'real' data strategy as such. Aside from people, data is the bigge...

Catapult appoints Chris Spencer as Venture Partner

Catapult Ventures has announced that Chris Spencer has been appointed as a Venture Partner with its GM&C Life Sciences Fund. Chris Spencer, who becomes the Fund’s fourth Venture Partner, will assess investment opportunities and work with the Fund’s smaller investments to help companies successfully grow, with a particular focus on digital health. Speaking on the new appointment, Ca...

Wednesday 8th November 2017

VETQAS Launch New Anthrax Training Aids

VETQAS (part of APHA Scientific) are pleased to announce the launch of a new laboratory training aid. A small number of stained and mounted Anthrax blood smears are now available on a first come first serve basis at a cost of £65 (ex VAT and delivery) The chances are that many of you will have not encountered Anthrax very frequently, if at all. So it can be hard to train your team to identif...

Monday 6th November 2017

£7 million Research and Development boost for North West businesses

Lancaster University is launching a £7.1 million low-carbon research and development programme to support small and medium sized enterprises (SMEs) in Lancashire, Cumbria, Cheshire and Liverpool.The award-winning Centre for Global Eco-Innovation, at Lancaster University, returns with more than 50 long-term projects involving three-year PhD, or one-year Master degree, high-calibre graduate re...

MAC Launches New Clinical Research Jobs Portal

Clinical Research Jobs:  MAC Clinical Research Launches its new personnel recruitment portal for Clinical Research Jobs.Welcome to Clinical Research Jobs, the personnel recruitment portal for MAC Clinical Research. MAC is the UK's largest clinical trials site management organisation committed to the recruitment and conduct of clinical trials through its own dedicated research sites.https://w...

Sunday 5th November 2017

Orla’s new patent granted in UK

Orla Protein Technologies Ltd, a leader in the design, engineering and immobilisation of proteins for surface applications, has been granted U.K. patent No. GB2527623 to its novel protein engineering and immobilisation platform (OrlaSURF) for immobilisation of proteins to polymeric surfaces.“This important piece of IP further strengthens our patent portfolio. We have built an exceptionally p...

SRG 2017 Salary Survey

SRG launched the 2017 Salary Survey in partnership with New Scientist on 21st February 2017! Based on responses from over 3,000 science professionals, this report provides the most comprehensive overview of salaries and market trends in the industry. Click here to request your copy!Also, check out the changes to the SRG North East branch which services businesses in the scientific sectors across ...

Saturday 28th October 2017

High Force Research continue expansion with appointment of Newcastle University postgraduate

North East-based chemical research and development company, High Force Research, has strengthened its Business Development team with the appointment of Newcastle University postgraduate Jennifer Wallis. Jennifer, who recently completed her EngD having previously studied a chemistry degree and MPhil at Newcastle University, has spent the last four years studying the synthesis of fluorescent dyes fo...

Biomedical Catalyst 2017 – Grant Funding Opportunity

Round 1 2017 of the Biomedical Catalyst is now open to projects from any sector or discipline that demonstrate the potential for significant, positive healthcare and economic impact. In October 2016, the Chancellor announced £100 million new funding to extend and enhance the Biomedical Catalyst supporting innovative UK life science companies to translate cutting-edge medical technologies in...

Thursday 26th October 2017

Innovation in Health & Life Sciences - Grant Funding Oppurtunity

This competition from Innovate UK is open to UK businesses, working alone or in collaborations that can include Universities and Research Institutes. The Call, valued at £15 Million, is for projects that support SME's to develop innovations in health and life sciences. Abbey+ as Bionow's Preferred Partner for R&D Funding aims to ensure that Bionow Members are fully supported with re...

Monday 23rd October 2017

One Nucleus Announces New Director

One Nucleus, the Cambridge based not-for-profit membership organisation for international life science and healthcare companies, is delighted to announce the appointment of Linda Summerton as a Director. Linda is Chief Executive of Immodulon and a Senior Partner with TranScrip Partners. She has over 25 years’ experience in the global pharmaceutical industry in large pharmaceutical companies,...


Quick Search
Advertisement
 

News Quicklinks